Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancersKwang‐Yu Chang, Li-Tzong Chen, Katherine Wu et al.|OncoImmunology|2021Cited by 44